Donald G. Fell - 04 Jun 2025 Form 4/A - Amendment Insider Report for Aspire Biopharma Holdings, Inc. (ASBP)

Role
Director
Signature
/s/ Donald G. Fell
Issuer symbol
ASBP
Transactions as of
04 Jun 2025
Net transactions value
+$7,800
Form type
4/A - Amendment
Filing time
10 Jun 2025, 17:25:23 UTC
Date Of Original Report
04 Jun 2025
Previous filing
20 Feb 2024
Next filing
23 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fell Donald G. Director 194 CANDELARO DRIVE, #233, HUMACAO, PUERTO RICO /s/ Donald G. Fell 10 Jun 2025 0001616905

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASBP Common Stock, par value $0.0001 Purchase $3,705 +9,500 $0.3900 9,500 04 Jun 2025 Direct
transaction ASBP Common Stock, par value $0.0001 Purchase $4,095 +10,500 +111% $0.3900 20,000 05 Jun 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This amendment is being filed to correct a scrivener's error in Column 4, to amend the previously indicated disposition code to an acquired code as this was a purchase by Mr. Fell.